Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
305 | 3 | NSAIDS//TOXIC EPIDERMAL NECROLYSIS//NON STEROIDAL ANTI INFLAMMATORY DRUGS | 41294 |
736 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//DICLOFENAC | 13004 |
923 | 2 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE | 11303 |
1577 | 2 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG ALLERGY | 7516 |
2220 | 2 | PARACETAMOL//METHOCARBAMOL//ACETAMINOPHEN | 5091 |
3388 | 2 | AGRANULOCYTOSIS//DRUG INDUCED THROMBOCYTOPENIA//DRUG DEPENDENT ANTIBODIES | 1754 |
3624 | 2 | DIPYRONE//ABSINTHE//THUJONE | 1349 |
3672 | 2 | ANALGESIC NEPHROPATHY//ACUTE INTERSTITIAL NEPHRITIS//TINU SYNDROME | 1277 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NSAIDS | authKW | 320435 | 3% | 34% | 1236 |
2 | TOXIC EPIDERMAL NECROLYSIS | authKW | 302496 | 1% | 84% | 471 |
3 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | authKW | 256554 | 2% | 33% | 1029 |
4 | STEVENS JOHNSON SYNDROME | authKW | 249619 | 1% | 77% | 426 |
5 | CYCLOOXYGENASE 2 | authKW | 208888 | 2% | 28% | 993 |
6 | CELECOXIB | authKW | 200842 | 2% | 42% | 626 |
7 | COX 2 | authKW | 193746 | 2% | 28% | 920 |
8 | CYCLOOXYGENASE | authKW | 169823 | 2% | 25% | 891 |
9 | COX 2 INHIBITORS | authKW | 160515 | 1% | 57% | 368 |
10 | DRUG ALLERGY | authKW | 157174 | 1% | 62% | 332 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 64918 | 25% | 1% | 10181 |
2 | Allergy | 45718 | 5% | 3% | 2097 |
3 | Chemistry, Analytical | 17199 | 10% | 1% | 4183 |
4 | Dermatology | 14238 | 5% | 1% | 2036 |
5 | Medicine, General & Internal | 13076 | 10% | 1% | 4018 |
6 | Chemistry, Medicinal | 12222 | 6% | 1% | 2401 |
7 | Rheumatology | 10728 | 3% | 1% | 1332 |
8 | Gastroenterology & Hepatology | 4951 | 4% | 1% | 1658 |
9 | Immunology | 2772 | 6% | 0% | 2393 |
10 | Oncology | 2647 | 6% | 0% | 2638 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 45395 | 0% | 49% | 123 |
2 | ALLERGY SERV | 31991 | 0% | 35% | 120 |
3 | CLIN RHEUMATOL CLIN IMMUNOL ALLERGOL | 29814 | 0% | 63% | 62 |
4 | UNIT ALLERG DIS | 28885 | 0% | 86% | 44 |
5 | PAIN NUFFIELD ANAESTHET | 22947 | 0% | 57% | 53 |
6 | ALLERGY UNIT | 17010 | 0% | 14% | 168 |
7 | DRUG HYPERSENSIT CLIN | 14539 | 0% | 68% | 28 |
8 | MINASE | 12000 | 0% | 26% | 62 |
9 | AB HANCOCK JR MEM CANC | 11846 | 0% | 43% | 36 |
10 | EXPT THER EUT PHARMACOINFORMAT | 11442 | 0% | 79% | 19 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 28866 | 0% | 49% | 78 |
2 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 18648 | 1% | 5% | 537 |
3 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 16483 | 0% | 11% | 205 |
4 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 15641 | 1% | 7% | 319 |
5 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 9037 | 1% | 5% | 228 |
6 | JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 8754 | 0% | 9% | 132 |
7 | CURRENT MEDICAL RESEARCH AND OPINION | 8504 | 1% | 5% | 232 |
8 | ALLERGY | 7803 | 1% | 4% | 262 |
9 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 7476 | 1% | 4% | 294 |
10 | JOURNAL OF CLINICAL PHARMACOLOGY | 7459 | 1% | 4% | 239 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NSAIDS | 320435 | 3% | 34% | 1236 | Search NSAIDS | Search NSAIDS |
2 | TOXIC EPIDERMAL NECROLYSIS | 302496 | 1% | 84% | 471 | Search TOXIC+EPIDERMAL+NECROLYSIS | Search TOXIC+EPIDERMAL+NECROLYSIS |
3 | NON STEROIDAL ANTI INFLAMMATORY DRUGS | 256554 | 2% | 33% | 1029 | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS | Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS |
4 | STEVENS JOHNSON SYNDROME | 249619 | 1% | 77% | 426 | Search STEVENS+JOHNSON+SYNDROME | Search STEVENS+JOHNSON+SYNDROME |
5 | CYCLOOXYGENASE 2 | 208888 | 2% | 28% | 993 | Search CYCLOOXYGENASE+2 | Search CYCLOOXYGENASE+2 |
6 | CELECOXIB | 200842 | 2% | 42% | 626 | Search CELECOXIB | Search CELECOXIB |
7 | COX 2 | 193746 | 2% | 28% | 920 | Search COX+2 | Search COX+2 |
8 | CYCLOOXYGENASE | 169823 | 2% | 25% | 891 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
9 | COX 2 INHIBITORS | 160515 | 1% | 57% | 368 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
10 | DRUG ALLERGY | 157174 | 1% | 62% | 332 | Search DRUG+ALLERGY | Search DRUG+ALLERGY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 3 |